Herlev Hospital
regionh.dkTotal trials
199
Active
23
Phase 3
3
Total enrollment
647,244
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Stroke6
- Pain5
- Melanoma5
- Neuromuscular Blockade5
- Pancreatic Cancer5
- Prostate Cancer5
- Malnutrition4
- Depression4
Frequently asked questions about Herlev Hospital
- How many clinical trials does Herlev Hospital have on ClinicalTrials.gov?
- Herlev Hospital is listed as the lead sponsor on 199 clinical trials in ClinicalTrials.gov, 23 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Herlev Hospital's trials are in Phase 3?
- 3 of Herlev Hospital's trials are in Phase 3.
- What therapeutic areas does Herlev Hospital focus on?
- Herlev Hospital's most-studied conditions on ClinicalTrials.gov are Stroke, Pain, Melanoma, Neuromuscular Blockade, Pancreatic Cancer.